EMPIRE STATE REALTY TRUST-A (ESRT) Fundamental Analysis & Valuation
NYSE:ESRT • US2921041065
Current stock price
5.17 USD
+0.09 (+1.77%)
At close:
5.17 USD
0 (0%)
After Hours:
This ESRT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ESRT Profitability Analysis
1.1 Basic Checks
- ESRT had positive earnings in the past year.
- In the past year ESRT had a positive cash flow from operations.
- ESRT had positive earnings in 4 of the past 5 years.
- ESRT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- ESRT has a Return On Assets of 0.97%. This is comparable to the rest of the industry: ESRT outperforms 54.47% of its industry peers.
- ESRT's Return On Equity of 3.98% is fine compared to the rest of the industry. ESRT outperforms 60.16% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 2.50%, ESRT is in line with its industry, outperforming 46.34% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for ESRT is in line with the industry average of 3.13%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.97% | ||
| ROE | 3.98% | ||
| ROIC | 2.5% |
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)4.43%
ROE(5y)3.19%
ROIC(3y)2.75%
ROIC(5y)2.48%
1.3 Margins
- ESRT has a Profit Margin (5.65%) which is comparable to the rest of the industry.
- ESRT's Profit Margin has improved in the last couple of years.
- ESRT has a Operating Margin (17.66%) which is in line with its industry peers.
- ESRT's Operating Margin has improved in the last couple of years.
- ESRT's Gross Margin of 53.70% is on the low side compared to the rest of the industry. ESRT is outperformed by 75.61% of its industry peers.
- ESRT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.66% | ||
| PM (TTM) | 5.65% | ||
| GM | 53.7% |
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
2. ESRT Health Analysis
2.1 Basic Checks
- ESRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, ESRT has more shares outstanding
- ESRT has less shares outstanding than it did 5 years ago.
- ESRT has a better debt/assets ratio than last year.
2.2 Solvency
- ESRT has an Altman-Z score of 0.48. This is a bad value and indicates that ESRT is not financially healthy and even has some risk of bankruptcy.
- ESRT has a Altman-Z score (0.48) which is comparable to the rest of the industry.
- ESRT has a Debt/Equity ratio of 2.18. This is a high value indicating a heavy dependency on external financing.
- Looking at the Debt to Equity ratio, with a value of 2.18, ESRT is doing worse than 69.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.48 |
ROIC/WACC0.43
WACC5.76%
2.3 Liquidity
- ESRT has a Current Ratio of 2.34. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 2.34, ESRT belongs to the best of the industry, outperforming 91.06% of the companies in the same industry.
- ESRT has a Quick Ratio of 2.34. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of ESRT (2.34) is better than 91.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.34 | ||
| Quick Ratio | 2.34 |
3. ESRT Growth Analysis
3.1 Past
- ESRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.10%, which is quite impressive.
- ESRT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.42% yearly.
- ESRT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.05%.
- ESRT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.75% yearly.
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%
3.2 Future
- ESRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -39.35% yearly.
- Based on estimates for the next years, ESRT will show a small growth in Revenue. The Revenue will grow by 2.24% on average per year.
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. ESRT Valuation Analysis
4.1 Price/Earnings Ratio
- ESRT is valuated cheaply with a Price/Earnings ratio of 5.94.
- ESRT's Price/Earnings ratio is rather cheap when compared to the industry. ESRT is cheaper than 98.37% of the companies in the same industry.
- ESRT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.54.
- With a Price/Forward Earnings ratio of 84.48, ESRT can be considered very expensive at the moment.
- ESRT's Price/Forward Earnings is on the same level as the industry average.
- ESRT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.94 | ||
| Fwd PE | 84.48 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ESRT indicates a rather cheap valuation: ESRT is cheaper than 86.18% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.41 |
4.3 Compensation for Growth
- A cheap valuation may be justified as ESRT's earnings are expected to decrease with -61.15% in the coming years.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
5. ESRT Dividend Analysis
5.1 Amount
- ESRT has a Yearly Dividend Yield of 2.71%. Purely for dividend investing, there may be better candidates out there.
- With a Dividend Yield of 2.71, ESRT pays less dividend than the industry average, which is at 7.32. 80.49% of the companies listed in the same industry pay a better dividend than ESRT!
- ESRT's Dividend Yield is a higher than the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.71% |
5.2 History
- The dividend of ESRT decreases each year by -6.73%.
- ESRT has been paying a dividend for at least 10 years, so it has a reliable track record.
- ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-6.73%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
- ESRT pays out 64.35% of its income as dividend. This is not a sustainable payout ratio.
- The Dividend Rate of ESRT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP64.35%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
ESRT Fundamentals: All Metrics, Ratios and Statistics
5.17
+0.09 (+1.77%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17 2026-02-17/amc
Earnings (Next)04-27 2026-04-27
Inst Owners103.01%
Inst Owner Change1.34%
Ins Owners0.08%
Ins Owner Change0.04%
Market Cap885.31M
Revenue(TTM)768.27M
Net Income(TTM)43.40M
Analysts75
Price Target7.51 (45.26%)
Short Float %5.37%
Short Ratio5.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.71% |
Yearly Dividend0.17
Dividend Growth(5Y)-6.73%
DP64.35%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-13 2026-03-13 (0.035)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.54%
PT rev (3m)-14.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.94 | ||
| Fwd PE | 84.48 | ||
| P/S | 1.15 | ||
| P/FCF | N/A | ||
| P/OCF | 3.55 | ||
| P/B | 0.81 | ||
| P/tB | 3.02 | ||
| EV/EBITDA | 9.41 |
EPS(TTM)0.87
EY16.83%
EPS(NY)0.06
Fwd EY1.18%
FCF(TTM)-2.11
FCFYN/A
OCF(TTM)1.45
OCFY28.13%
SpS4.49
BVpS6.36
TBVpS1.71
PEG (NY)N/A
PEG (5Y)0.1
Graham Number11.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.97% | ||
| ROE | 3.98% | ||
| ROCE | 3.16% | ||
| ROIC | 2.5% | ||
| ROICexc | 2.58% | ||
| ROICexgc | 3.19% | ||
| OM | 17.66% | ||
| PM (TTM) | 5.65% | ||
| GM | 53.7% | ||
| FCFM | N/A |
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)4.43%
ROE(5y)3.19%
ROIC(3y)2.75%
ROIC(5y)2.48%
ROICexc(3y)2.96%
ROICexc(5y)2.68%
ROICexgc(3y)3.73%
ROICexgc(5y)3.4%
ROCE(3y)3.48%
ROCE(5y)3.14%
ROICexgc growth 3Y-2.22%
ROICexgc growth 5Y10.35%
ROICexc growth 3Y-1.13%
ROICexc growth 5Y11.75%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.18 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.18 | ||
| Cap/Depr | 313.47% | ||
| Cap/Sales | 79.47% | ||
| Interest Coverage | 1.45 | ||
| Cash Conversion | 75.38% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.34 | ||
| Quick Ratio | 2.34 | ||
| Altman-Z | 0.48 |
F-Score6
WACC5.76%
ROIC/WACC0.43
Cap/Depr(3y)200.4%
Cap/Depr(5y)163.62%
Cap/Sales(3y)50.04%
Cap/Sales(5y)43.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%
EBIT growth 1Y-14.53%
EBIT growth 3Y2.22%
EBIT growth 5Y15.89%
EBIT Next Year144.54%
EBIT Next 3Y36.3%
EBIT Next 5Y22.27%
FCF growth 1Y-231.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.54%
OCF growth 3Y5.65%
OCF growth 5Y6.44%
EMPIRE STATE REALTY TRUST-A / ESRT Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?
ChartMill assigns a fundamental rating of 4 / 10 to ESRT.
What is the valuation status for ESRT stock?
ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.
What is the profitability of ESRT stock?
EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 5 / 10.
What is the valuation of EMPIRE STATE REALTY TRUST-A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EMPIRE STATE REALTY TRUST-A (ESRT) is 5.94 and the Price/Book (PB) ratio is 0.81.
What is the financial health of EMPIRE STATE REALTY TRUST-A (ESRT) stock?
The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.